CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
Our immune system implements an array of strategies to combat threatening infections. White blood cells called cytotoxic T ...
A shift toward personalized treatments and programmable cell therapies opens new doors for scientists engineering T cell-based treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results